Your SlideShare is downloading. ×
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

ReportsnReports – Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)

530

Published on

A biochip is defined as a collection of miniaturized test sites (microarrays) arranged on a solid platform that allows multiple tests to be performed at the same time with increased efficiency and …

A biochip is defined as a collection of miniaturized test sites (microarrays) arranged on a solid platform that allows multiple tests to be performed at the same time with increased efficiency and higher speed. The global biochip market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 billion by 2015; growing at a CAGR of 16.7%. This growth is attributed to increasing applications in cancer diagnostics and expression profiling, the boom in personalized medicine, and government funding.

Published in: Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
530
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
26
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & CellArrays) Trends & Global Forecast (2010-2015)ReportsnReports.com adds MarketsandMarkets Market Research Report “ Biochips Market(DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & GlobalForecast (2010-2015)’’ to its store.A biochip is defined as a collection of miniaturized test sites (microarrays) arranged on asolid platform that allows multiple tests to be performed at the same time with increasedefficiency and higher speed. The global biochip market is studied by the types and keyapplications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 billion by2015; growing at a CAGR of 16.7%. This growth is attributed to increasing applications incancer diagnostics and expression profiling, the boom in personalized medicine, andgovernment funding.DNA microarrays represent the largest segment of this market and will continue to be thelargest contributor during the study period (2010-2015). However, this segment will beclosely followed by lab-on-chip (LOC) in the coming years due to its wide applications andincreased adoption by various biotechnology, pharmaceutical companies, and researchlaboratories. The third largest segment – protein microarrays will be the fastest growingsegment; forecasted to grow at a CAGR of 19.9% during the study period due to advancesin the fields of genomics and proteomics and improvements in the field of recombinantproteins.Reverse phase protein microarrays designed for targeted therapies in cancer holds promisein the global biochip market in the next 5-10 years. These microarrays provide increasedaccuracy and enhanced efficacy for the detection of rare molecules as compared to existingmicroarray surfaces for cancer research & diagnosis to help understand the proteins intumor cells. Thus, they have helped open the avenues for personalized methods for cancertherapy.The market of Asia will account for a bulk of the future biochip market growth due to itshigh growth potential and huge demand from emerging economies such as India and China– the large pool of heterogeneous patient population, and increasing R&D investment inthese countries. The top players in the biochip market such as Affymetrix, Inc., Illumina,Inc., and Fluidigm Corporation have relocated their manufacturing base to Singapore to takeadvantage of the benefits the country offers; coupled with rising demand from neighboringcountries of Asia. The players also benefit from a well-established semiconductormanufacturing base including chip technologies. Singapore has made focused efforts toattract life sciences corporates with dedicated investments accounting for 3% of thecountry’s GDP. It came up with its R&D center – Singapore’s Biopolis R&D center in 2003-2004 and is home to the Genome Institute of Singapore.Scope of the reportThis research report categorizes the global biochips market on the basis of applications,types, and geography; forecasting revenues and analyzing trends in each of the followingsubmarkets:
  • 2. On the basis of applications:DNA applications: Gene expression, SNP genotyping, cancer diagnosis & treatment,genomics, agricultural biotechnology, drug discovery, and others.Lab on chip applications: Drug discovery, genomics, diagnostics, proteomics, IVD & POC,high throughput screening, and others.Protein microarray applications: Expression profiling, proteomics, high throughputscreening, diagnostics, drug discovery, and others.Other array applications: Expression profiling, cancer diagnostics, toxicogenomics,genomics, drug discovery, and others.On the basis of types:DNA microarrays, lab on chip, protein microarrays, other arrays (cell arrays andtissue arrays)On the basis of geography:North America, Europe, Asia, and Rest of the World.Each section will provide market data, market drivers, trends and opportunities, top-sellingproducts, key players, and competitive outlook. It will also provide market tables forcovering the sub-segments. In addition, the report will throw light on more than 20company profiles covering all the sub-segments.TABLE OF CONTENTS1 INTRODUCTION1.1 KEY TAKE-AWAYS1.2 REPORT DESCRIPTION1.3 MARKETS COVERED1.4 STAKEHOLDERS1.5 RESEARCH METHODOLOGY1.5.1 MARKET SIZE1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES1.5.4 MARKET SHARE1.5.5 ASSUMPTIONS MADE FOR THE REPORT2 EXECUTIVE SUMMARY2.1 OVERVIEW OF THE MARKET2.2 KEY FINDINGS2.3 RECOMMENDATIONS2.3.1 APPLICATION OF REVERSE PHASE PROTEIN MICROARRAYS IN CANCER DIAGNOSIS ISA LUCRATIVE INVESTMENT OPTION3 MARKET OVERVIEW
  • 3. 3.1 INTRODUCTION3.2 BURNING ISSUE3.2.1 EMERGENCE OF NEW DISEASES & DISEASE COMPLEXITY CATALYZE ADOPTION OFBIOCHIPS IN DIAGNOSTICS3.3 WINNING IMPERATIVES3.3.1 STANDARDIZATION IS A NECESSITY3.3.2 COST3.3.3 NEED OF CROSS COMPATIBILITY3.3.4 END-TO-END SOLUTIONS3.4 MARKET DYNAMICS3.4.1 DRIVERS3.4.1.1 Growth in personalized medicine3.4.1.2 Increase Government funding3.4.1.3 Cancer diagnosis & treatment is on a rise3.4.1.4 Technical advances3.4.2 RESTRAINTS3.4.2.1 Knowledge constraints with respect to technical know-how3.4.2.2 Lack of healthcare coverage restricts the adoption3.4.3 OPPORTUNITIES3.4.3.1 Growth of market in the sub-continent of Asia3.4.3.2 Widening applications market3.4.4 TRENDS3.4.4.1 Robust deals & alliances3.4.4.2 Relocating manufacturing facilities to gain competitive edge3.4.4.2.1 Advantage Singapore3.4.4.3 Next generation technology for LOC3.4.4.3.1 Lab on CD-ROM3.4.4.3.2 EFAD chip technology3.4.4.4 Outsourcing of the biochip technology3.4.4.4.1 Reduction in the labor cost3.4.4.4.2 Increased focus on core business3.4.4.4.3 Risk reduction3.4.4.4.4 Utilization of business expertise3.4.4.4.5 Reduction in capital expenditure3.5 MARKET BREAKDOWN3.6 END-USER ANALYSIS3.7 MARKET SHARE ANALYSIS3.7.1 DNA MICROARRAY MARKET SHARE ANALYSIS3.7.2 LOC/MICROFLUIDICS MARKET SHARE ANALYSIS3.7.3 PROTEIN MICROARRAY MARKET SHARE ANALYSIS4 GLOBAL DNA MICROARRAY MARKET4.1 INTRODUCTION4.2 DNA MICROARRAY MARKET, BY APPLICATIONS4.2.1 GENE EXPRESSION4.2.2 SNP GENOTYPING4.2.3 CANCER DIAGNOSIS & TREATMENT
  • 4. 4.2.4 GENOMICS4.2.5 AGRICULTURAL BIOTECHNOLOGY4.2.6 DRUG DISCOVERY4.2.7 OTHERS5 GLOBAL LAB-ON-CHIP/MICROFLUIDICS MARKET5.1 INTRODUCTION5.2 LOC/MICROFLUIDICS MARKET, BY APPLICATIONS5.2.1 HIGH THROUGHPUT SCREENING5.2.2 GENOMICS5.2.3 PROTEOMICS5.2.4 DRUG DISCOVERY5.2.5 IVD & POC5.2.6 DIAGNOSTICS5.2.7 OTHERS6 GLOBAL PROTEIN MICROARRAY MARKET6.1 INTRODUCTION6.2 PROTEIN MICROARRAY MARKET, BY TYPES6.2.1 EXPRESSIONAL PROTEIN MICROARRAY6.2.2 FUNCTIONAL PROTEIN MICROARRAY6.2.3 REVERSE PHASE PROTEIN MICROARRAY6.3 PROTEIN MICROARRAY MARKET, BY APPLICATIONS6.3.1 EXPRESSION PROFILING6.3.2 PROTEOMICS6.3.3 HIGH THROUGHPUT SCREENING6.3.4 DIAGNOSTICS6.3.5 DRUG DISCOVERY6.3.6 OTHERS7 GLOBAL OTHER ARRAYS MARKET7.1 OTHER ARRAYS MARKET, BY TYPES7.1.1 CELL ARRAY7.1.2 TISSUE ARRAY7.1.2.1 FFPE Arrays7.1.2.2 Frozen Arrays7.2 OTHER ARRAYS MARKET, BY APPLICATIONS7.2.1 EXPRESSION PROFILING7.2.2 CANCER DIAGNOSTICS7.2.3 TOXICOGENOMICS7.2.4 GENOMICS7.2.5 DRUG DISCOVERY7.2.6 OTHERS8 GLOBAL BIOCHIP MARKET, BY GEOGRAPHY
  • 5. 8.1 INTRODUCTION8.2 NORTH AMERICA8.3 EUROPE8.4 ASIA8.5 ROW9 COMPETITIVE LANDSCAPE9.1 KEY STRATEGIES10 COMPANY PROFILES10.1 AFFYMETRIX INC10.1.1 OVERVIEW10.1.2 FINANCIALS10.1.3 PRODUCTS & SERVICES10.1.4 STRATEGY10.1.5 DEVELOPMENTS10.2 AGILENT TECHNOLOGIES INC10.2.1 OVERVIEW10.2.2 FINANCIALS10.2.3 PRODUCTS & SERVICES10.2.4 STRATEGY10.2.5 DEVELOPMENTS10.3 BIOCHAIN INSTITUTE INC10.3.1 OVERVIEW10.3.2 FINANCIALS10.3.3 PRODUCTS & SERVICES10.3.4 STRATEGY10.3.5 DEVELOPMENTS10.4 BIOMÉRIEUX SA10.4.1 OVERVIEW10.4.2 FINANCIALS10.4.3 PRODUCTS & SERVICES10.4.4 STRATEGY10.4.5 DEVELOPMENTS10.5 BIO-RAD LABORATORIES INC10.5.1 OVERVIEW10.5.2 FINANCIALS10.5.3 PRODUCTS & SERVICES10.5.4 STRATEGY10.5.5 DEVELOPMENTS10.6 CALIPER LIFE SCIENCES INC10.6.1 OVERVIEW10.6.2 FINANCIALS10.6.3 PRODUCTS & SERVICES10.6.4 STRATEGY10.6.5 DEVELOPMENTS10.7 CEPHEID INC
  • 6. 10.7.1 OVERVIEW10.7.2 FINANCIALS10.7.3 PRODUCTS & SERVICES10.7.4 STRATEGY10.7.5 DEVELOPMENTS10.8 CYBRDI INC10.8.1 OVERVIEW10.8.2 FINANCIALS10.8.3 PRODUCTS & SERVICES10.8.4 STRATEGY10.8.5 DEVELOPMENTS10.9 EMD MILLIPORE10.9.1 OVERVIEW10.9.2 FINANCIALS10.9.3 PRODUCTS & SERVICES10.9.4 STRATEGY10.9.5 DEVELOPMENTS10.10 FLUIDIGM CORP10.10.1 OVERVIEW10.10.2 FINANCIALS10.10.3 PRODUCTS & SERVICES10.10.4 STRATEGY10.10.5 DEVELOPMENTS10.11 GAMIDA FOR LIFE GROUP10.11.1 OVERVIEW10.11.2 FINANCIALS10.11.3 PRODUCTS & SERVICES10.11.4 STRATEGY10.11.5 DEVELOPMENTS10.12 ILLUMINA INC10.12.1 OVERVIEW10.12.2 FINANCIALS10.12.3 PRODUCTS & SERVICES10.12.4 STRATEGY10.12.5 DEVELOPMENTS10.13 LIFE TECHNOLOGIES CORP10.13.1 OVERVIEW10.13.2 FINANCIALS10.13.3 PRODUCTS & SERVICES10.13.4 STRATEGY10.13.5 DEVELOPMENTS10.14 ORIGENE TECHNOLOGIES INC10.14.1 OVERVIEW10.14.2 FINANCIALS10.14.3 PRODUCTS & SERVICES10.14.4 STRATEGY10.14.5 DEVELOPMENTS10.15 PERKINELMER INC10.15.1 OVERVIEW
  • 7. 10.15.2 FINANCIALS10.15.3 PRODUCTS & SERVICES10.15.4 STRATEGY10.15.5 DEVELOPMENTS10.16 ROCHE NIMBLEGEN INC10.16.1 OVERVIEW10.16.2 FINANCIALS10.16.3 PRODUCTS & SERVICES10.16.4 STRATEGY10.16.5 DEVELOPMENTS10.17 SEQUENOM10.17.1 OVERVIEW10.17.2 FINANCIALS10.17.3 PRODUCTS & SERVICES10.17.4 STRATEGY10.17.5 DEVELOPMENTS10.18 SIGMA ALDRICH CORP10.18.1 OVERVIEW10.18.2 FINANCIALS10.18.3 PRODUCTS & SERVICES10.18.4 STRATEGY10.18.5 DEVELOPMENTS10.19 OTHERS10.19.1 IMGENEX10.19.1.1 Overview10.19.1.2 Financials10.19.1.3 Products & services10.19.2 ISU ABXIS CO. LTD10.19.2.1 Overview10.19.2.2 Financials10.19.2.3 Products & services10.19.3 US BIOMAX INC10.19.3.1 Overview10.19.3.2 Financials10.19.3.3 Products & servicesLIST OF TABLESTABLE 1 GLOBAL BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)TABLE 2 LIFE EXPECTANCY AT BIRTHTABLE 3 TAX ENVIRONMENTTABLE 4 TAX ENVIRONMENT: FOR NEW START UP COMPANIES IN SINGAPORETABLE 5 DNA MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 6 TOP FIVE DNA MICROARRAY TECHNOLOGIESTABLE 7 COMPARISON BETWEEN PHOTOLITHOGRAPHY & INKJET TECHNOLOGYTABLE 8 GLOBAL DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 9 DNA MICROARRAY: GENE EXPRESSION MARKET REVENUE, BY GEOGRAPHY, 2008– 2015 ($MILLION)
  • 8. TABLE 10 DNA MICROARRAY: SNP GENOTYPING MARKET REVENUE, BY GEOGRAPHY, 2008– 2015 ($MILLION)TABLE 11 DNA MICROARRAY: CANCER DIAGNOSIS & TREATMENT MARKET REVENUE, BYGEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 12 DNA MICROARRAY: GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015($MILLION)TABLE 13 DNA MICROARRAY: AGRICULTURAL BIOTECHNOLOGY MARKET REVENUE, BYGEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 14 DNA MICROARRAY: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008– 2015 ($MILLION)TABLE 15 DNA MICROARRAY: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015($MILLION)TABLE 16 LOC MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 17 GLOBAL LOC MARKET REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)TABLE 18 COMPARATIVE ANALYSIS OF MICROFLUIDIC ASSAY TECHNIQUESTABLE 19 LOC: HTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 20 LOC: GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 21 LOC: PROTEOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 22 LOC: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015($MILLION)TABLE 23 LOC: IVD & POC MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 24 LOC: DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015($MILLION)TABLE 25 LOC: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 26 PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015($MILLION)TABLE 27 PROTEIN MICROARRAY MANUFACTURING TECHNOLOGIESTABLE 28 GLOBAL PROTEIN MICROARRAY MARKET REVENUE, BY TYPES, 2008 – 2015($MILLION)TABLE 29 EXPRESSIONAL PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008– 2015 ($MILLION)TABLE 30 FUNCTIONAL PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 –2015 ($MILLION)TABLE 31 REVERSE PHASE PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY,2008 – 2015 ($MILLION)TABLE 32 GLOBAL PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 –2015 ($MILLION)TABLE 33 PROTEIN MICROARRAY APPLICATIONS IN EXPRESSION PROFILINGTABLE 34 PROTEIN MICROARRAY: EXPRESSION PROFILING MARKET REVENUE, BYGEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 35 PROTEIN MICROARRAY APPLICATIONS IN PROTEOMICSTABLE 36 PROTEIN MICROARRAY: PROTEOMICS MARKET REVENUE, BY GEOGRAPHY, 2008– 2015 ($MILLION)TABLE 37 PROTEIN MICROARRAY: HTS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015($MILLION)TABLE 38 PROTEIN MICROARRAY: DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2008– 2015 ($MILLION)TABLE 39 PROTEIN MICROARRAY: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY,2008 – 2015 ($MILLION)
  • 9. TABLE 40 PROTEIN MICROARRAY: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 –2015 ($MILLION)TABLE 41 GLOBAL OTHER ARRAYS MARKET REVENUE, BY TYPES, 2008 – 2015 ($MILLION)TABLE 42 OTHER ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 43 CELL ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 44 GLOBAL TISSUE ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 – 2015($MILLION)TABLE 45 TISSUE ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 46 FFPE ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 47 FROZEN ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 48 GLOBAL OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 49 OTHER ARRAYS: EXPRESSION PROFILING MARKET REVENUE, BY GEOGRAPHY,2008 – 2015 ($MILLION)TABLE 50 OTHER ARRAYS: CANCER DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY,2008 – 2015 ($MILLION)TABLE 51 OTHER ARRAYS: TOXICOGENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 –2015 ($MILLION)TABLE 52 OTHER ARRAYS: GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015($MILLION)TABLE 53 OTHER ARRAYS: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 –2015 ($MILLION)TABLE 54 OTHER ARRAYS: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015($MILLION)TABLE 55 BIOCHIP MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)TABLE 56 NORTH AMERICA: BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 – 2015($MILLION)TABLE 57 NORTH AMERICA: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008– 2015 ($MILLION)TABLE 58 NORTH AMERICA: PROTEIN MICROARRAY MARKET REVENUE,BY PRODUCTS, 2008– 2015 ($MILLION)TABLE 59 NORTH AMERICA: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS,2008 – 2015 ($MILLION)TABLE 60 NORTH AMERICA: LOC MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 61 NORTH AMERICA: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 –2015 ($MILLION)TABLE 62 NORTH AMERICA: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 –2015 ($MILLION)TABLE 63 EUROPE: BIOCHIP MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 – 2015($MILLION)TABLE 64 EUROPE: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 65 EUROPE: PROTEIN MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 – 2015($MILLION)TABLE 66 EUROPE: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 –2015 ($MILLION)TABLE 67 EUROPE: LOC MARKET REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)TABLE 68 EUROPE: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 – 2015
  • 10. ($MILLION)TABLE 69 EUROPE: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 70 ASIA: BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)TABLE 71 ASIA: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 72 ASIA: PROTEIN MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 – 2015($MILLION)TABLE 73 ASIA: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 74 ASIA: LOC MARKET REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)TABLE 75 ASIA: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 – 2015($MILLION)TABLE 76 ASIA: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 77 ROW: BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)TABLE 78 ROW: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 79 ROW: PROTEIN MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 – 2015($MILLION)TABLE 80 ROW: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 81 ROW: LOC MARKET REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)TABLE 82 ROW: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 – 2015($MILLION)TABLE 83 ROW: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 – 2015($MILLION)TABLE 84 NEW PRODUCT LAUNCHESTABLE 85 AGREEMENTS & COLLABORATIONSTABLE 86 MERGERS & ACQUISITIONSTABLE 87 AFFYMETRIX INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($MILLION)TABLE 88 AFFYMETRIX INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)TABLE 89 AFFYMETRIX INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)TABLE 90 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($MILLION)TABLE 91 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010($MILLION)TABLE 92 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010($MILLION)TABLE 93 BIOMÉRIEUX SA: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)TABLE 94 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($MILLION)TABLE 95 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010($MILLION)TABLE 96 BIO-RAD LABORATORIES: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010($MILLION)TABLE 97 CALIPER LIFE SCIENCES INC: TOTAL REVENUE AND R&D EXPENSES, 2008 –2010 ($THOUSAND)
  • 11. TABLE 98 CALIPER LIFE SCIENCES INC:TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010($THOUSAND)TABLE 99 CALIPER LIFE SCIENCES INC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2010($THOUSAND)TABLE 100 CEPHEID INC.: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($THOUSAND)TABLE 101 CEPHEID: TOTAL PRODUCT REVENUE, BY GEOGRAPHY, 2008 – 2010($THOUSAND)TABLE 102 CEPHEID: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($THOUSAND)TABLE 103 CEPHEID: TOTAL REVENUE, BY SUB-SEGMENTS, 2008 – 2010 ($THOUSAND)TABLE 104 CYBRDI INC: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2010 ($THOUSAND)TABLE 105 CYBRDI INC: TOTAL REVENUE, BY COUNTRY, 2009 – 2010 ($THOUSAND)TABLE 106 CYBRDI INC: TOTAL REVENUE, BY SEGMENTS ($THOUSAND)TABLE 107 FLUIDIGM CORP: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($THOUSAND)TABLE 108 FLUIDIGM CORP: TOTAL PRODUCTS REVENUE, BY GEOGRAPHY, 2008 – 2010($THOUSAND)TABLE 109 FLUIDIGM CORP: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($THOUSAND)TABLE 110 ILLUMINA INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($THOUSAND)TABLE 111 ILLUMINA INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($THOUSAND)TABLE 112 ILLUMINA INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($THOUSAND)TABLE 113 LIFE TECHNOLOGIES CORP: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($MILLION)TABLE 114 LIFE TECHNOLOGIES CORP: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010($THOUSAND)TABLE 115 LIFE TECHNOLOGIES CORP: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010($MILLION)TABLE 116 PERKINELMER INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($MILLION)TABLE 117 PERKINELMER INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)TABLE 118 PERKINELMER INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)TABLE 119 SEQUENOM INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($THOUSAND)TABLE 120 SEQUENOM INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($THOUSAND)TABLE 121 SEQUENOM INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($THOUSAND)TABLE 122 SIGMA-ALDRICH: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($MILLION)TABLE 123 SIGMA-ALDRICH: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)TABLE 124 SIGMA-ALDRICH: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)TABLE 125 ISU ABXIS CO. LTD: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010($THOUSAND)LIST OF FIGURESFIGURE 1 BIOCHIP MARKET SEGMENTATIONFIGURE 2 GLOBAL BIOCHIP MARKET, 2010 VS 2015FIGURE 3 MARKET COMPOSITION, 2010FIGURE 4 COMPOSITION OF END-USERS, 2010
  • 12. FIGURE 5 DNA MICROARRAY MARKET SHARE ANALYSIS, BY COMPANIES, 2010FIGURE 6 GLOBAL LAB-ON-CHIP MARKET SHARE ANALYSIS, BY COMPANIES, 2010FIGURE 7 GLOBAL PROTEIN MICROARRAY MARKET SHARE ANALYSIS, BY COMPANIES, 2010FIGURE 8 DNA MICROARRAY MARKET – APPLICATIONS MARKET SEGMENTATIONFIGURE 9 LAB-ON-CHIP APPLICATIONS MARKET SEGMENTATIONFIGURE 10 APPLICATION OF LAB-ON-CHIP TECHNOLOGY IN DRUG DISCOVERYFIGURE 11 PROTEIN MICROARRAY APPLICATIONS MARKET SEGMENTATIONFIGURE 12 KEY GROWTH STRATEGIES, JANUARY 2008 – JUNE 2011Latest Market Research ReportsGlobal Nuclear Medicine (Medical Isotopes/ Radioisotopes/ Radiopharmaceuticals) Market inPET/SPECT Imaging and Therapy – Competitive Landscape, Current trends and Forecasts(2010 – 2015)Medical Imaging Markets: Image-Guided SurgeryJuly Monthly Deal Roundup – FoodserviceThe Future of Interior Products in Spain to 2015: Demand to Gather Pace from 2012Global and China Rubber Auxiliary Industry Report, 2010-2011China Ceramic Industry Report, 2010-2011China Online Video Industry Report, 2011About Us:ReportsnReports is an online library of over 75,000 market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr. Priyank7557 Rambler road,Suite 727, Dallas, TX 75231Tel: +1-888-989-8004 EXT 106E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit Our Market Research Blog

×